Glyconeb 25mcg Injection
Marketer
AXA Parenterals Ltd
Salt Composition
Glycopyrrolate (25mcg)
Overview Glyconeb 25mcg Injection
Glyconeb 25mcg Injection, an anticholinergic agent, is administered pre- or intra-operatively to suppress secretions and counteract the neuromuscular blocking effects of certain surgical medications. It also offers relief from peptic ulcers in cases where oral administration is unsuitable. Administration is strictly by a healthcare professional. Complete disclosure of all other medications to your physician is crucial, as interactions are possible. Continue treatment as directed; premature cessation may lead to symptom recurrence and condition exacerbation. Common adverse events include xerostomia, urinary retention, blurred vision, photosensitivity, mydriasis, cycloplegia, tachycardia, increased intraocular pressure, bradycardia, palpitations, and decreased perspiration. Alcohol consumption should be avoided due to potential additive sedative effects. Prior notification of your doctor regarding glaucoma, myasthenia gravis, cardiac insufficiency, or hypertension is essential.
Primary Ingredients of Glyconeb 25mcg Injection
No text provided to rephrase.
Uses of Glyconeb 25mcg Injection
Complete Anesthesia | Gastric and Duodenal Ulcers
Major Benefits of Glyconeb 25mcg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Glyconeb 25mcg Injection:
- Urinary retention
- Blurred vision
- Dilatation of pupil
- Cycloplegia (paralysis of the ciliary muscle of the eye)
- Ocular hyperemia
- Slow heart rate
- Palpitations
- Reduced sweating
- Increased heart rate
- Increased intraocular pressure
How to use Glyconeb 25mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Glyconeb 25mcg Injection works:
Glyconeb 25mcg Injection, an anticholinergic agent, counteracts the effects of the neurotransmitter acetylcholine within the central nervous system.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Glyconeb 25mcg Injection lacks established safety data. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Glyconeb 25mcg is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Glyconeb 25mcg Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant harm. However, prolonged Glyconeb 25mcg Injection administration may decrease breast milk supply.
DrivingUNSAFE
Administering Glyconeb 25mcg Injection may induce adverse reactions impacting driving capabilities. Glyconeb 25mcg Injection can impair vision and coordination, potentially compromising safe driving.
KidneyCAUTION
Patients with kidney impairment should use Glyconeb 25mcg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Glyconeb 25mcg Injection use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Glyconeb 25mcg Injection :
NA
Facts to Know About Glyconeb 25mcg Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Man-made quaternary ammonium compounds |
| Potential for Dependence | None. |
| Type of Medication | Gastrointestinal system |
| Mechanism of Action | Parasympatholytic - Anesthesia |
3,018 People bought this recently